Factors associated with non-response to lactulose therapy in cirrhotic patients with minimal hepatic encephalopathy

Authors

  • Shireen Ahmed Department of Gastroenterology Hepatobiliary and Pancreatic Disorders, BIRDEM General Hospital, Dhaka
  • Md Golam Azam Department of Gastroenterology Hepatobiliary and Pancreatic Disorders, BIRDEM General Hospital, Dhaka
  • Indrajit Kumar Datta Department of Gastroenterology Hepatobiliary and Pancreatic Disorders, BIRDEM General Hospital, Dhaka
  • Md Nazmul Hoque Department of Gastroenterology Hepatobiliary and Pancreatic Disorders, BIRDEM General Hospital, Dhaka
  • Tareq M Bhuiyan Department of Gastroenterology Hepatobiliary and Pancreatic Disorders, BIRDEM General Hospital, Dhaka

Abstract

Background and objectives: Minimal hepatic encephalopathy (MHE) impairs health related quality of life and predicts overt hepatic encephalopathy (HE) in cirrhotic patients. Lactulose is effective in the treatment of MHE. But the response to lactulose treatment depends on several factors. This study was aimed to find out the contributing factors to non-response to lactulose therapy.

Materials and methods: The study was carried out at the BIRDEM general hospital from September, 2013 to March, 2015. Sixty patients were enrolled to assess the response of lactulose therapy in cirrhotic patients with MHE. MHE was diagnosed based on abnormal psychometric tests namely, number connection test (NCT), digit symbol test (DST) and high serum ammonia level. A daily dose of 30-60 ml of lactulose was given to all patients for one month. The response to treatment with regard to MHE was determined after one month using defined criteria. The response was graded as responder and non-responder.

Results: The mean age of the study population was 57.0±10.3 years. Out of 60 cases, 46 (77%) were male and 39 (65%) had diabetes. Out of 60 enrolled MHE cases, 16 (27%) had Child-Turcotte-Pugh-A (CTP-A) score and 44 (73%) belonged to CTP-B & C category. Out of 60 MHE cases, 23 (38.3%) showed improvement in their MHE status based on normalization of psychometric tests and reduction of serum ammonia level to ≤32 μmol/L. Age, gender and diabetes were not associated with the response to lactulose therapy. Low baseline arterial pressure was significantly (p=0.003) associated with non-response to lactulose treatment. The mean baseline ammonia level was higher significantly among the nonresponders compared to the responders (83.6±21.4 μmol/L vs 58.8±19.8 μmol/L, p<0.001). Compared to responders, low serum sodium and potassium and raised serum bilirubin levels of non-responders at baseline were found significantly (p<0.05) associated with non-response to one month of lactulose treatment. Initial hemoglobulin, peripheral leucocyte and platelet counts did not have any effect on the response to lactulose treatment in MHE cases.

Conclusions: The status of MHE in patients with cirrhosis improved by one-month treatment with lactulose. Baseline low arterial pressure, hyperammonemia, hypokalemia and hyponatremia were major contributors to non-response to lactulose therapy. The findings of the study would be useful in treating patients of cirrhosis with MHE.

IMC J Med Sci 2018; 12(1): 15-21

Downloads

Download data is not yet available.
Abstract
26
PDF
30

Downloads

Published

2018-01-02

How to Cite

Ahmed, S., Azam, M. G., Datta, I. K., Hoque, M. N., & Bhuiyan, T. M. (2018). Factors associated with non-response to lactulose therapy in cirrhotic patients with minimal hepatic encephalopathy. IMC Journal of Medical Science, 12(1), 15–21. Retrieved from https://banglajol.info/index.php/IMCJMS/article/view/35172

Issue

Vol. 12 No. 1 (2018)

Section

Original Articles

License

Authors who publish in IMCJMS agree to the following terms that:

  1. Authors retain copyright and grant IMCJMS the right of first publication of the work.

  2. Creative Commons Licence
    Articles in IMCJMS are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  3. Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.